Safety and Immunogenicity of a 4-Component GMMA-based Shigella Vaccine in Healthy European Adults: Stage 1 of a Randomized, Controlled Phase I/II Clinical Trial Isabel Leroux-Roels , Cathy Maes , Francesca Mancini , Bart Jacobs , Eleanna Sarakinou , Azhar Alhatemi , Jasper Joye , Silvia Grappi , Giulia Luna Cilio , Alimamy Serry-Bangura , Claudia G Vitali , Pietro Ferruzzi , Elisa Marchetti , Francesca Necchi , Rino Rappuoli , Iris De Ryck , Jochen Auerbach , Anna M Colucci , Omar Rossi , Valentino Conti , Francesco Berlanda Scorza , Ashwani Kumar Arora , Francesca Micoli , Audino Podda , Usman N Nakakana , Francesco Citiulo , Emilia Cappelletti , Gianmarco Gasperini , Carlo Giannelli , Alessandra Acquaviva , Luigi Sollai , Renzo Alfini , Maria Grazia Aruta , Laura Bartle Martin The Journal of Infectious Diseases（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
